Patient-Centered Models of HCV Care for People Who Inject Drugs

NACompletedINTERVENTIONAL
Enrollment

755

Participants

Timeline

Start Date

September 15, 2016

Primary Completion Date

March 20, 2020

Study Completion Date

August 4, 2021

Conditions
Hepatitis CMedication Adherence
Interventions
BEHAVIORAL

Patient Navigation

The study will follow a PN model (Check Hep C) developed by NYCDOH in collaboration with Montefiore and the community. HCV PNs will provide the following interventions to those randomized to the PN arm: coordination of HCV treatment; health promotion; assisting patients to overcome barriers; and psychosocial support.

BEHAVIORAL

modified Directly Observed Therapy

Subjects will be observed taking medications, a minimum of 5 times a week for those enrolled in the OAT setting, and a minimum of 3 times a week for those enrolled in the community health clinic setting.

Trial Locations (1)

10467

Alain Litwin, The Bronx

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

University of Rhode Island

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

West Virginia University

OTHER

collaborator

University of New Mexico

OTHER

collaborator

University of California

OTHER

collaborator

University of Washington

OTHER

collaborator

Montefiore Medical Center

OTHER

lead

Prisma Health-Upstate

OTHER

NCT02824640 - Patient-Centered Models of HCV Care for People Who Inject Drugs | Biotech Hunter | Biotech Hunter